Annovis Bio, a clinical-stage biopharmaceutical company, has recently provided transparent insights into its ongoing Parkinson’s study. The company aims to...
Coffee and tea are two of the most popular beverages consumed worldwide. Not only do they provide a much-needed energy...
Understanding the Qualifying Conditions for a Medical Marijuana Card in Pennsylvania, Ohio, and West Virginia: Insights into the Medical Marijuana...
Salk Institute Professor Ronald Evans receives prestigious Japan Prize recognition The Salk Institute for Biological Studies is proud to announce...
Roche Withdraws Support from AC Immune: What Does It Mean for the Biotech Company? In a surprising move, Roche, one...
Understanding the Potential of Epigenetic Editing: Harnessing the Power of CRISPR without DNA Alteration In recent years, the revolutionary gene-editing...
A Comprehensive Overview of the Top 10 Biotech Funding Rounds in 2023 The biotech industry has been experiencing significant growth...
MIT Introduces Groundbreaking Method for Noninvasive RNA Expression Analysis Researchers at the Massachusetts Institute of Technology (MIT) have developed a...
A Step-by-Step Guide on Obtaining a Medical Card in Texas Medical marijuana has been gaining recognition as an effective treatment...
Anavex’s Cash Reserves Remain as Sole Asset Following Multiple Study Failures of Promising Drug Anavex Life Sciences, a biopharmaceutical company...
Zevra Therapeutics, a biopharmaceutical company focused on developing innovative treatments for rare and neurodegenerative diseases, has recently resubmitted its New...
BrainStorm Cell Therapeutics, a leading biotechnology company, has recently been granted patents for its allogeneic exosome platform-product in the treatment...
The Impact of ABCA7 Deficiency on Neuronal Dysregulation through Changes in Mitochondrial Lipid Metabolism – Insights from Molecular Psychiatry Mitochondria,...
Dispelling the Myth: A Comprehensive Review of Over 32,000 Cannabis Studies Published in the Last 10 Years Cannabis, also known...
Preliminary Data from FTD-GRN Gene Therapy Trial Revealed by Passage Bio Frontotemporal dementia (FTD) is a devastating neurodegenerative disorder that...
